Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow ALB
Albemarle Corporation (ALB) EPS (diluted)
Albemarle Corporation's EPS (diluted) for fiscal 2025 was −$5.76, compared with −$11.20 in fiscal 2024. Over the twelve months to 30 June 2026 it was $0.27. Over the past ten years it has ranged from −$11.20 (fiscal 2024) to $22.84 (fiscal 2022); the current reading is higher than 18% of that period. Albemarle Corporation ranks 30th of 56 Specialty Chemicals companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$5.76 | — |
| FY2024 | −$11.20 | — |
| FY2023 | $13.36 | (41.51%) |
| FY2022 | $22.84 | 2,054.72% |
| FY2021 | $1.06 | (69.89%) |
| FY2020 | $3.52 | (29.88%) |
| FY2019 | $5.02 | (20.82%) |
| FY2018 | $6.34 | 1,193.88% |
| FY2017 | $0.49 | (91.37%) |
| FY2016 | $5.68 | 89.33% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $3.52 | 50.43% |
| Mar 2026 | $2.34 | — |
| Dec 2025 | −$3.87 | — |
| Sep 2025 | −$1.72 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NEU NewMarket Corporation compare | $46.48 |
| RPM RPM International Inc. compare | $5.41 |
| SQM Sociedad Quimica y Minera S.A. compare | $5.33 |
| SOLS Solstice Advanced Materials Inc. compare | $2.16 |
| ESI Element Solutions Inc. compare | $0.74 |
| DD DuPont de Nemours, Inc. compare | $0.45 |
| ALB Albemarle Corporation | $0.27 |
| WLK Westlake Corporation compare | −$9.58 |
| SSL Sasol Ltd. compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ALB
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement